Prevention

The COVID-19 pandemic has put the brakes on HIV cure research, but investigators report recent progress and promising pathways nonetheless.

Armand Balboni, MD, PHD, CEO of Appili Therapeutics, discusses work with favipiravir on a new front for the drug — the global search for COVID-19 treatment and prevention therapies.

Barriers to recommended vaccine coverage for low-income American adults include disparity in Medicaid programs and low reimbursement amounts, a new study found.

The attenuated virus in oral polio vaccines has developed the ability to evolve and spread to humans. Now, investigators have developed a new vaccine without the ability to make such changes.

Disparate reimbursement policies disincentivize clinicians from vaccinating adults with lower incomes.

MenQuadfi is the only FDA approved quadrivalent meningococcal vaccine that is indicated for individuals 2 through 56 years of age and older.

Health care settings such as hospitals, clinics, assisted living facilities, and physician offices depend on the circulation of clean air that is free of mold, bacteria, viruses, and fungi.

The authors of the review recommend the continued use of MMR vaccines on a mass scale.

A new survey found that parents in Spain were the most supportive of vaccinations when compared with their counterparts in 4 other European countries.

Whole genome sequencing revealed little overlap between MDROs found in pets and pet owners.

Oral third-generation cephalosporins failed to treat Shigella sonnei infections despite in vitro susceptibility in 4 cases.

Deaths were reported among all age groups of health care personnel infected with COVID-19.

Gain more insight on clinical trials evaluating investigational agents for COVID-19.

The USPSTF commissioned a review on the impact of asymptomatic bacterial vaginosis screening and treatment on pregnant women with respect to preterm birth.

Rural counties are less likely to have an experienced HIV clinician, despite increasing HIV incidence.

In mouse models, the vaccine produced antibodies for SARS-CoV-2 which may offer sufficient protection.

Tina Q. Tan, MD, discusses vaccine misinformation.

A study has examined the availability of negative vaccine information online.

Colleen Kelley, MD, MPH, describes what's on the horizon in HIV prevention.

The 20vPnC pneumococcal conjugate vaccine candidate was found comparable to licensed products in safety and immunogenicity.

In a new study, 38% of inpatients with bacteremia at an academic medical center had low procalcitonin values.

Ian Frank, MD, explains the "Ending the Epidemic" initiative.

The CRACKLE-2 study examined clinical characteristics of 3 CRE subsets in the US.

Colleen Kelley, MD, MPH, describes the current state of HIV vaccine efforts.

A new study demonstrates that the introduction of a universal immunization program had positive impact on the educational attainment of people in India’s school system.

Colleen Kelley, MD, MPH, discusses the importance of targeted youth HIV prevention measures.